Nabriva Therapeutics plc
NBRVF
$0.0001
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -89.11% | -94.68% | -73.96% | -71.84% | -67.23% |
| Total Receivables | -64.09% | -4.52% | -47.13% | -17.59% | 6.78% |
| Inventory | -- | -42.25% | -33.31% | 11.24% | 53.61% |
| Prepaid Expenses | -47.76% | -51.41% | -58.31% | -45.20% | -46.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.16% | -29.31% | -29.71% | -32.40% | -32.22% |
| Total Current Assets | -81.67% | -63.66% | -61.25% | -46.20% | -42.62% |
|
|
|||||
| Total Current Assets | -81.67% | -63.66% | -61.25% | -46.20% | -42.62% |
| Net Property, Plant & Equipment | 19.42% | 45.30% | 20.17% | 1.38% | -41.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -92.31% | -90.48% | -90.32% | -82.93% | -75.93% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.26% | 0.00% | -0.53% | -0.79% | -0.53% |
| Total Assets | -80.73% | -63.00% | -60.74% | -45.87% | -42.47% |
|
|
|||||
| Total Accounts Payable | 1,207.18% | 342.21% | 24.22% | 163.89% | -32.17% |
| Total Accrued Expenses | -9.37% | 47.80% | -24.31% | -17.24% | 2.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -97.04% | -95.31% | 28.37% | 106.22% | 263.36% |
| Total Finance Division Other Current Liabilities | 39.90% | 203.79% | 114.39% | -38.21% | -59.87% |
| Total Other Current Liabilities | 39.90% | 203.79% | 114.39% | -38.21% | -59.87% |
| Total Current Liabilities | 35.54% | 72.08% | 23.57% | 9.71% | 0.63% |
|
|
|||||
| Total Current Liabilities | 35.54% | 72.08% | 23.57% | 9.71% | 0.63% |
| Long-Term Debt | -32.81% | -91.19% | -90.90% | -92.28% | -91.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -20.72% | -63.64% | -49.79% | -38.38% | -53.31% |
| Total Liabilities | 32.59% | 35.64% | 3.31% | -12.45% | -22.59% |
|
|
|||||
| Common Stock & APIC | 0.63% | 0.78% | 1.10% | 1.52% | 1.87% |
| Retained Earnings | -8.90% | -8.90% | -9.60% | -8.15% | -8.15% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -147.16% | -109.76% | -93.83% | -59.51% | -49.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -147.16% | -109.76% | -93.83% | -59.51% | -49.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -147.16% | -109.76% | -93.83% | -59.51% | -49.99% |
|
|
|||||